Human immunodeficiency virus type 1 nef expression prevents AP-2-mediated internalization of the major histocompatibility complex class II-associated invariant chain.
The lentiviral Nef protein has been studied extensively for its ability to induce the downregulation of several immunoreceptors on the surfaces of infected cells. However, Nef expression is unique in inducing highly effective upregulation of the major histocompatibility complex class II-associated chaperone invariant (Ii) chain complexes in different cell types. Under normal conditions, endocytosis of the Ii chain and other molecules, like the transferrin receptor and CD4, is rapid and AP-2 dependent. Human immunodeficiency virus type 1 (HIV-1) Nef expression strongly reduces the internalization of the Ii chain, enhances that of CD4, and does not modify transferrin uptake. The mutation of AP-2 binding motifs LL164 and DD174 in Nef leads to the inhibition of Ii chain upregulation. In AP-2-depleted cells, surface levels of the Ii chain are high and remain unmodified by Nef expression, further indicating that Nef regulates Ii chain internalization via the AP-2 pathway. Immunoprecipitation experiments revealed that the Ii chain can interact with Nef in a dileucine-dependent manner. Importantly, we have shown that Nef-induced CD4 downregulation and Ii chain upregulation are genetically distinguishable. We have identified natural nef alleles that have lost one of the two functions but not the other one. Moreover, we have characterized Nef mutant forms possessing a similar phenotype in the context of HIV-1 infection. Therefore, the Nef-induced accumulation of Ii chain complexes at the cell surface probably results from a complex mechanism leading to the impairment of AP-2-mediated endocytosis rather than from direct competition between Nef and the Ii chain for binding AP-2.
Toussaint
Hélène
H
Institut Curie, Centre de Recherche, Paris F-75248, France.
Gobert
François-Xavier
FX
Schindler
Michael
M
Banning
Carina
C
Kozik
Patrycja
P
Jouve
Mabel
M
Kirchhoff
Frank
F
Benaroch
Philippe
P
D000944:Antigens, Differentiation, B-Lymphocyte; D002460:Cell Line; D018274:Electroporation; D004705:Endocytosis; D015967:Gene Expression Regulation, Viral; D015693:Gene Products, nef / Q000378:metabolism*; D015497:HIV-1 / Q000235:genetics / Q000502:physiology*; D006367:HeLa Cells; D000949:Histocompatibility Antigens Class II / Q000502:physiology*; D006801:Humans; D019169:Jurkat Cells; D007668:Kidney / Q000166:cytology; D034741:RNA, Small Interfering / Q000378:metabolism; D050656:Transcription Factor AP-2 / Q000502:physiology*; D014162:Transfection
D000944:Antigens, Differentiation, B-Lymphocyte; D015693:Gene Products, nef; D000949:Histocompatibility Antigens Class II; D034741:RNA, Small Interfering; D050656:Transcription Factor AP-2; C045084:invariant chain